Showing results (891-900 of 983) with videos related to

Sort By:
Pageof 99
Plos One|May 22, 2013
Identification of a mitochondrial target of thiazolidinedione insulin sensitizers (mTOT)--relationship to newly identified mitochondrial pyruvate carrier proteinsJerry R Colca, William G McDonald, Gregory S Cavey, et al.
Neuro-Oncology|November 19, 2024
Phase 2 trial of veliparib, local irradiation, and temozolomide in patients with newly diagnosed high-grade glioma: a Children's Oncology Group studyMatthias A Karajannis, Arzu Onar-Thomas, Tong Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2026
The first-in-human ENCIT01 trial comparing second- versus third-generation L1CAM-specific CAR T cells in patients with primary refractory or relapsed neuroblastomaNavin Pinto, Annette Künkele, Catherine M Albert, et al.
Neuro-Oncology|November 1, 2020
Optimal therapeutic targeting by HDAC inhibition in biopsy-derived treatment-naïve diffuse midline glioma modelsNicholas A Vitanza, Matt C Biery, Carrie Myers, et al.
Physical Review Letters|June 1, 2004
New approach for measuring properties of rp-process nucleiR R C Clement, D Bazin, W Benenson, et al.
Leukemia|May 31, 2017
MUC1 inhibition leads to decrease in PD-L1 levels via upregulation of miRNAsA R Pyzer, D Stroopinsky, J Rosenblatt, et al.
Journal of the Royal Society, Interface|August 24, 2022
The role of wingbeat frequency and amplitude in flight powerKrishnamoorthy Krishnan, Baptiste Garde, Ashley Bennison, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2019
Receding ice drove parallel expansions in Southern Ocean penguinsTheresa L Cole, Ludovic Dutoit, Nicolas Dussex, et al.
Cell|January 24, 2025
Cardiometabolic benefits of a non-industrialized-type diet are linked to gut microbiome modulationFuyong Li, Anissa M Armet, Katri Korpela, et al.
Neuro-Oncology|March 12, 2025
Locoregional Infusion of EGFR806-CAR T Cells for Recurrent or Refractory Pediatric CNS Tumors: Results of the Completed BrainChild02 Phase 1 Clinical TrialJuliane Gust, Bonnie L Cole, Rebecca Ronsley, et al.
Pageof 99